@FierceBiotech: EuroBiotech: EU IPOs obliterate recent highs, U.K. VC funding tops $700M, Woodford backs microbiome play. Report | Follow @FierceBiotech
@JohnCFierce: Interviewed the CEO at the new CAR-T player. Their CSO also worked on Bellicum program. Story | Follow @JohnCFierce
@DamianFierce: $MDCO's Clive Meanwell has by far the best name among biopharma CEOs. At least until someone appoints Guy Smiley. | Follow @DamianFierce
> Sen. Elizabeth Warren (D-MA) has a novel plan for punishing Big Pharma malfeasance: Drugmakers that settle federal criminal charges would have to bequeath 1% of their annual profits to the National Institutes of Health for 5 years thereafter. "It's like a swear jar," Warren said. More
> Former Chimerix ($CMRX) CEO Kenneth Moch, once at the center of a compassionate use controversy over the company's antiviral treatment, unexpectedly stepped down last year. Bloomberg Businessweek takes a detailed look at just what happened. Item
> U.K. life sciences firms banked about $713 million in venture capital last year, according to CB Insights, a 41% jump over 2013. News
Medical Device News
@FierceMedDev: Roche's Ventana inches closer to FDA approval for lung cancer companion Dx. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Welch Allyn buys eye exam provider, signaling move into services. Article | Follow @VarunSaxena2
@EmilyWFierce: Au revoir, Weber; Bonjour, Bohuon? FiercePharma article | Follow @EmilyWFierce
> Profit down 12% at Intuitive Surgical, but procedure volume up due to strength abroad and in general surgery. More
> France's bioMérieux and Astute Medical join forces on acute kidney injury test. Article
Pharma News
@FiercePharma: ICYMI yesterday: Pfizer wins recommendation for Prevenar expansion in Europe. Story | Follow @FiercePharma
@EricPFierce: UAE-based Gulf Pharmaceuticals intends to build a $50M insulin plant in Ethiopia. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal. Article | Follow @CarlyHFierce
> Challenger says 2015 a year to send out your resume, pharma folk. Story
> GSK refutes reports the ax is about to fall on jobs in China. News